Effect of puerarin on bone formation

Osteoarthritis and Cartilage

Volumn 15, Issue 8, 2007, Pages 894-899

  Wong, R ^a   Rabie, B ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Bone graft; Bone repair; Phytoestrogen; Pueraria lobata; Puerarin

Indexed keywords

COLLAGEN; PHYTOESTROGEN; PUERARIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEFECT; BONE GRAFT; CARTILAGE MATRIX; CHINESE MEDICINE; CONTROLLED STUDY; DISSECTION; DRUG STRUCTURE; HISTOLOGY; IMAGE ANALYSIS; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; PUERARIA; QUANTITATIVE ANALYSIS; RABBIT; SKULL; TISSUE SECTION;

ANIMALS; BONE TRANSPLANTATION; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; FRACTURE HEALING; FRACTURES, BONE; ISOFLAVONES; OSTEOGENESIS; PARIETAL BONE; RABBITS; VASODILATOR AGENTS;

EID: 34547697916     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2007.02.009     Document Type: Article

References (40)

1. Lane J.M., Tomin E., and Bostrom M.P.G. Biosynthetic bone grafting. Clin Orthop 367S (1999) S107-S117
2. Younger E.M., and Chapman M.W. Morbidity at bone graft donor sites. J Orthop Trauma 3 (1989) 192-195
3. Zins J.E., and Whitaker L.A. Membranous versus endochondral bone: implications for craniofacial reconstruction. Plast Reconst Surg 72 (1983) 778-784
4. Strong D.M., Friedlaender G.E., Tomford W.W., Springfield D.S., Shives T.C., Burchardt H., et al. Immunologic responses in human recipients of osseous and osteochondral allografts. Clin Orthop 326 (1996) 107-114
5. Turner R.T., Riggs B.L., and Spelsberg T.C. Skeletal effects of estrogen. Endocr Rev 15 (1994) 275-300
6. Chow J., Tobias J.H., Colston K.W., and Chambers T.J. Estrogen maintains trabecular bone volume in rats not only by suppression of bone-resorption but also by stimulation of bone-formation. J Clin Invest 89 (1992) 74-78
7. Qu Q., Perala-Heape M., Kapanen A., Dahllund J., Salo J., Vaananen H.K., et al. Estrogen enhances differentiation of osteoblasts in mouse bone marrow culture. Bone 22 (1998) 201-209
8. Takano-Yamamoto T., and Rodan G.A. Direct effects of 17-β-estradiol on trabecular bone in ovariectomized rats. Proc Natl Acad Sci U S A 87 (1990) 2172-2176
9. Qu Q., Harkonen P.L., Monkkonen J., and Vaananen H.K. Conditioned medium of estrogen-treated osteoblasts inhibits osteoclast maturation and function in vitro. Bone 25 (1999) 211-215
10. Branca F. Dietary phyto-oestrogens and bone health. Proc Nutr Soc 62 (2003) 877-887
11. Bhathena S.J., and Velasquez M.T. Beneficial role of dietary phytoestrogens in obesity and diabetes. Am J Clin Nutr 76 (2002) 1191-1201
12. Duncan A.M., Phipps W.R., and Kurzer M.S. Phyto-oestrogens. Best Pract Res Clin Endocrinol Metab 17 (2003) 253-271
13. Kanno S., Hirano S., and Kayama F. Effects of phytoestrogens and environmental estrogens on osteoblastic differentiation in MC3T3-E1 cells. Toxicology 196 (2004) 137-145
14. Chueh F.S., Chang C.P., Chio C.C., and Lin M.T. Puerarin acts through brain serotonergic mechanisms to induce thermal effects. J Pharmacol Sci 96 (2004) 420-427
15. Wang X., Wu J., Chiba H., Umegaki K., Yamada K., and Ishimi Y. Puerariae radix prevents bone loss in ovariectomized mice. J Bone Miner Metab 21 (2003) 268-275
16. Overstreet D.H., Lee Y.W., Rezvani A.H., Pei Y.H., Criswell H.E., and Janowsky D.S. Suppression of alcohol intake after administration of the Chinese herbal medicine, NPI-028, and its derivatives. Alcohol Clin Exp Res 20 (1996) 221-227
17. Wang L.Y., Zhao A.P., and Chai X.S. Effects of puerarin on cat vascular smooth muscle in vitro. Acta Pharmacol Sin 15 (1994) 180-182
18. Jiang R.W., Lau K.M., Lam H.M., Yam W.S., Leung L.K., Choi K.L., et al. A comparative study on aqueous root extracts of Pueraria thomsonii and Pueraria lobata by antioxidant assay and HPLC fingerprint analysis. J Ethnopharmacol 96 (2005) 133-138
19. Wong R.W.K., and Rabie A.B.M. A quantitative assessment of the healing of intramembranous and endochondral autogenous bone grafts. Eur J Orthod 21 (1999) 119-126
20. Wong R.W.K., and Rabie A.B.M. Statin collagen grafts used to repair defects in the parietal bone of rabbits. Br J Oral Maxillofac Surg 41 (2003) 244-248
21. Dang Z.C., Audinot V., Papapoulos S.E., Boutin J.A., and Löwik C.W.G.M. Peroxisome proliferator-activated receptor γ (PPARγ) as a molecular target for the soy phytoestrogen genistein. J Biol Chem 278 (2003) 962-967
22. Dang Z.C., and Lowik C.W. The balance between concurrent activation of ERs and PPARs determines daidzein-induced osteogenesis and adipogenesis. J Bone Miner Res 19 (2004) 853-861
23. Viereck V., Gründker C., Blaschke S., Siggelkow H., Emons G., and Hofbauer L.C. Phytoestrogen genistein stimulates the production of osteoprotegerin by human trabecular osteoblasts. J Cell Biochem 84 (2002) 725-735
24. Setchell K.D., and Lydeking-Olsen E. Dietary phytoestrogens and their effect on bone: evidence from in vitro and in vivo, human observational, and dietary intervention studies. Am J Clin Nutr 78 (2003) 593S-609S
25. Pettersson K., Delaunay F., and Gustafsson J.A. Estrogen receptor β acts as a dominant regulator of estrogen signaling. Oncogene 19 (2000) 4970-4978
26. An J., Tzagarakis-Foster C., Scharschmidt T.C., Lomri N., and Leitman D.C. Estrogen receptor β-selective transcriptional activity and recruitment of coregulators by phytoestrogens. J Biol Chem 276 (2001) 17808-17814
27. Agarwal R. Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents. Biochem Pharmacol 60 (2000) 1051-1059
28. Barnes S. Soy isoflavones-phytoestrogens and what else?. J Nutr 134 (2004) 1225S-1228S
29. Akune T., Ohba S., Kamekura S., Yamaguchi M., Chung U.I., Kubota N., et al. PPAR insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J Clin Invest 113 (2004) 846-855
30. Jia T.L., Wang H.Z., Xie L.P., Wang X.Y., and Zhang R.Q. Daidzein enhances osteoblast growth that may be mediated by increased bone morphogenetic protein (BMP) production. Biochem Pharmacol 65 (2003) 709-715
31. Zhou S., Turgeman G., Harris S.E., Leitman D.C., Komm B.S., Bodine P.V.N., et al. Estrogens activate bone morphogenetic protein-2 gene transcription in mouse mesenchymal stem cells. Mol Endocrinol 17 (2003) 56-66
32. Rabie A.B.M., and Lie K.J. Integration of endochondral bone grafts in the presence of demineralized bone matrix. Int J Oral Maxillofac Surg 25 (1996) 311-318
33. Rabie A.B.M., Wong R.W.K., and Hägg U. Bone induction using autogenous bone mixed with demineralised bone matrices. Aust Orthod J 15 (1999) 269-275
34. Rabie A.B.M., Wong R.W.K., and Hägg U. Composite autogenous bone and demineralised bone matrices used to repair defects in the parietal bone of rabbits. Br J Oral Maxillofac Surg 38 (2000) 565-570
35. Nevins M., Kirker-Head C., and Nevins M. Bone formation in the goat maxillary sinus induced by absorbable collagen sponge implants impregnated with recombinant human bone morphogenetic protein - 2. Int J Periodont Restorative Dent 16 (1996) 9-19
36. Li S.T. Collagen as a delivery vehicle for bone morphogenetic protein (BMP). Trans Orthop Res Soc 21 (1996) 647
37. Boyne P.J., Marx R.E., and Nevins M. A feasibility study evaluating rhBMP - 2/absorbable collagen sponge for maxillary sinus floor augmentation. Int J Periodont Restorative Dent 17 (1997) 11-25
38. Chin M., Ng T., Torn W.K., and Carstens M. Repair of alveolar clefts with recombinant human bone morphogenetic protein (rhBMP-2) in patients with clefts. J Craniofac Surg 5 (2005) 778-789
39. Bouxsein M.L., Turek T.J., and Blake C.A. Recombinant human bone morphogenetic protein - 2 accelerates healing in a rabbit ulnar osteotomy model. J Bone Joint Surg Am 83A (2001) 1219-1230
40. Chen X. The clinical observation of puerarin injection on unstable angina pectoris. Zhong Yao Cai 27 (2004) 77-78